HUM: Humana Inc. Stock

SIC 6324 – Hospital and Medical Service Plans

Valuation
Market Cap ($M) 38,992.70
Enterprise Value ($M) 46,935.70
Book Value ($M) 16,318.00
Book Value / Share 135.36
Price / Book 2.39
NCAV ($M) -761.00
NCAV / Share -6.31
Price / NCAV -51.24

Profitability (mra)
Return on Invested Capital (ROIC) 0.08
Return on Assets (ROA) 0.05
Return on Equity (ROE) 0.15

Liquidity (mrq)
Quick Ratio 1.59
Current Ratio 1.59

Balance Sheet (mrq) ($M)
Current Assets 29,986.00
Assets 47,065.00
Liabilities 30,747.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 106,374.00
Operating Income 4,554.00
Net Income 2,489.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 3,981.00
Cash from Investing -3,492.00
Cash from Financing -856.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-16 13G/A Price T Rowe Associates Inc /md/ 3.20 0.00
02-13 13G/A Vanguard Group Inc 9.07 -1.65
02-09 13G/A Fmr Llc 3.89 -30.20
02-08 13G/A Wellington Management Group Llp 4.36 -29.54
02-07 13G/A BlackRock Inc. 9.10 -3.27

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUAN
2023-08-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO
2023-04-26 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-18 265,732 1,557,433 17.06
2024-04-17 226,066 1,958,774 11.54
2024-04-16 211,598 1,683,413 12.57
2024-04-15 187,741 1,184,742 15.85

(click for more detail)

Similar Companies
CNC – Centene Corporation CNO – CNO Financial Group, Inc.
ELV – Elevance Health, Inc. MOH – Molina Healthcare, Inc.
OSCR – Oscar Health, Inc.


Financial data and stock pages provided by
Fintel.io